Short Interest in Scienture Holdings, Inc. (NASDAQ:SCNX) Increases By 177.8%

Scienture Holdings, Inc. (NASDAQ:SCNX) was the recipient of a large growth in short interest in the month of July. As of July 15th, there was short interest totaling 2,600,386 shares, a growth of 177.8% from the June 30th total of 935,988 shares. Based on an average trading volume of 7,329,646 shares, the short-interest ratio is presently 0.4 days. Approximately 8.1% of the shares of the company are short sold.

Institutional Investors Weigh In On Scienture

An institutional investor recently bought a new position in Scienture stock. Virtu Financial LLC acquired a new stake in shares of Scienture Holdings, Inc. (NASDAQ:SCNX) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 89,930 shares of the company’s stock, valued at approximately $46,000. Virtu Financial LLC owned approximately 0.22% of Scienture at the end of the most recent quarter. 5.68% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Scienture in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $1.50.

Scienture Price Performance

NASDAQ:SCNX opened at $0.38 on Wednesday. Scienture has a 1 year low of $0.24 and a 1 year high of $2.60. The company has a market cap of $15.24 million, a P/E ratio of -0.15 and a beta of 3.28. The stock’s fifty day moving average price is $0.38 and its two-hundred day moving average price is $0.41.

Scienture (NASDAQ:SCNX) last issued its quarterly earnings data on Friday, May 15th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.15. The company had revenue of $0.06 million for the quarter, compared to analysts’ expectations of $0.40 million.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.